Philadelphia Chromosome Positive Recruiting Phase 1 Trials for Cyclophosphamide (DB00531)

Also known as: Philadelphia chromosome positive

IndicationStatusPhase
DBCOND0046287 (Philadelphia Chromosome Positive)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03233854CD19/CD22 Chimeric Antigen Receptor(CAR) T Cells in Adults With Recurrent/Refractory B Cell MalignanciesTreatment
NCT03241940Phase I CD19/CD22 Chimeric Antigen Receptor T Cells in Peds Recurrent/Refractory B Cell MalignanciesTreatment